MS Society of Canada Research News

MS Society of Canada Research News http://mssociety.ca/en/research/researchlibrary.htm News in Research Mon, 20 Jun 2011 02:05:00 EST en-can Increased Risk of Multiple Sclerosis Following Occurrence of Shingles http://mssociety.ca/en/research/medmmo_20110610.htm http://mssociety.ca/en/research/medmmo_20110610.htm 20 Jun 2011 02:05:00 EST MS Research Progress Takes Center Stage at American Academy of Neurology’s Annual Meeting http://mssociety.ca/en/research/medmmo_20110511.htm http://mssociety.ca/en/research/medmmo_20110511.htm 11 May 2011 11:20:00 EST First Oral Disease-Modifying Therapy Approved in Canada (Gilenya) http://mssociety.ca/en/research/medmmo_20110310.htm http://mssociety.ca/en/research/medmmo_20110310.htm 10 Mar 2011 10:30:00 EST Research Teams Report Progress from First Six Months of 2-Year Projects Focusing on CCSVI and MS http://mssociety.ca/en/research/medmmo_20110131.htm http://mssociety.ca/en/research/medmmo_20110131.htm 31 Jan 2011 16:00:00 EST Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients http://mssociety.ca/en/research/medmmo_20101118_2.htm http://mssociety.ca/en/research/medmmo_20101118_2.htm 18 Nov 2010 04:05:00 EST Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study. http://mssociety.ca/en/research/medmmo_20101118.htm http://mssociety.ca/en/research/medmmo_20101118.htm 18 Nov 2010 04:05:00 EST Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon beta http://mssociety.ca/en/research/medmmo_20101104.htm http://mssociety.ca/en/research/medmmo_20101104.htm 04 Nov 2010 09:00:00 EST MS Researchers Share Progress at Annual ECTRIMS Conference http://mssociety.ca/en/research/medmmo_20101102.htm http://mssociety.ca/en/research/medmmo_20101102.htm 02 Nov 2010 16:40:00 EST Abdominal massage for the alleviation of constipation symptoms in people with multiple sclerosis: a randomized controlled feasibility study http://mssociety.ca/en/research/medmmo_20101027_2.htm http://mssociety.ca/en/research/medmmo_20101027_2.htm 27 Oct 2010 10:26:00 EST A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis http://mssociety.ca/en/research/medmmo_20101027.htm http://mssociety.ca/en/research/medmmo_20101027.htm 27 Oct 2010 10:26:00 EST Dextromethorphan Plus Ultra Low-Dose Quinidine Reduces Pseudobulbar Affect http://mssociety.ca/en/research/medmmo_20101021_2.htm http://mssociety.ca/en/research/medmmo_20101021_2.htm 21 Oct 2010 09:55:00 EST MS quality of life, depression, and fatigue improve after mindfulness training http://mssociety.ca/en/research/medmmo_20101021.htm http://mssociety.ca/en/research/medmmo_20101021.htm 21 Oct 2010 09:47:00 EST Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue http://mssociety.ca/en/research/medmmo_20101014.htm http://mssociety.ca/en/research/medmmo_20101014.htm 14 Oct 2010 10:02:00 EST Pathophysiology of multiple sclerosis and the place of teriflunomide http://mssociety.ca/en/research/medmmo_20101008.htm http://mssociety.ca/en/research/medmmo_20101008.htm 08 Oct 2010 12:12:00 EST Calnexin Deficiency Leads to Dysmyelination http://mssociety.ca/en/research/medmmo_20100916_2.htm http://mssociety.ca/en/research/medmmo_20100916_2.htm 16 Sep 2010 02:23:00 EST The natural history of secondary progressive multiple sclerosis http://mssociety.ca/en/research/medmmo_20100916.htm http://mssociety.ca/en/research/medmmo_20100916.htm 16 Sep 2010 09:51:00 EST A method for evaluating treatment switching criteria in multiple sclerosis http://mssociety.ca/en/research/medmmo_20100909_2.htm http://mssociety.ca/en/research/medmmo_20100909_2.htm 09 Sep 2010 11:41:00 EST Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study http://mssociety.ca/en/research/medmmo_20100909.htm http://mssociety.ca/en/research/medmmo_20100909.htm 09 Sep 2010 11:41:00 EST Emerging effects of comorbidities on multiple sclerosis http://mssociety.ca/en/research/medmmo_20100827_2.htm http://mssociety.ca/en/research/medmmo_20100827_2.htm 27 Aug 2010 10:35:00 EST Fatigue, sleepiness, and physical activity in patients with multiple sclerosis http://mssociety.ca/en/research/medmmo_20100827.htm http://mssociety.ca/en/research/medmmo_20100827.htm 27 Aug 2010 10:35:00 EST A ChIP-seq-defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution http://mssociety.ca/en/research/medmmo_20100823.htm http://mssociety.ca/en/research/medmmo_20100823.htm 23 Aug 2010 17:00:00 EST Modifiable factors influencing relapses and disability in multiple sclerosis http://mssociety.ca/en/research/medmmo_20100819_4.htm http://mssociety.ca/en/research/medmmo_20100819_4.htm 19 Aug 2010 11:30:00 EST Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical Studies http://mssociety.ca/en/research/medmmo_20100819_3.htm http://mssociety.ca/en/research/medmmo_20100819_3.htm 19 Aug 2010 11:30:00 EST Recent Papers Highlight Difficulty of Studying Long-Term Impact on Progression of MS Disease-Modifying Therapies http://mssociety.ca/en/research/medmmo_20100819_2.htm http://mssociety.ca/en/research/medmmo_20100819_2.htm 19 Aug 2010 11:30:00 EST Emerging Therapies in Relapsing-Remitting Multiple Sclerosis http://mssociety.ca/en/research/medmmo_20100819.htm http://mssociety.ca/en/research/medmmo_20100819.htm 19 Aug 2010 11:30:00 EST Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis http://mssociety.ca/en/research/medmmo_20100810_3.htm http://mssociety.ca/en/research/medmmo_20100810_3.htm 10 Aug 2010 05:14:00 EST Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated http://mssociety.ca/en/research/medmmo_20100810_2.htm http://mssociety.ca/en/research/medmmo_20100810_2.htm 10 Aug 2010 05:14:00 EST Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity http://mssociety.ca/en/research/medmmo_20100810.htm http://mssociety.ca/en/research/medmmo_20100810.htm 10 Aug 2010 05:14:00 EST A Home-Based Walking Program Using Rhythmic Auditory Stimulation Improves Gait Performance in Patients With Multiple Sclerosis: A Pilot Study http://mssociety.ca/en/research/medmmo_20100805_3.htm http://mssociety.ca/en/research/medmmo_20100805_3.htm 05 Aug 2010 10:25:00 EST The Effect of Microvascular Decompression in Patients With Multiple Sclerosis and Trigeminal Neuralgia http://mssociety.ca/en/research/medmmo_20100805_2.htm http://mssociety.ca/en/research/medmmo_20100805_2.htm 05 Aug 2010 10:25:00 EST The natural history of secondary progressive multiple sclerosis http://mssociety.ca/en/research/medmmo_20100805.htm http://mssociety.ca/en/research/medmmo_20100805.htm 05 Aug 2010 10:25:00 EST Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group http://mssociety.ca/en/research/medmmo_20100729_4.htm http://mssociety.ca/en/research/medmmo_20100729_4.htm 29 Jul 2010 17:38:00 EST Executive Functioning in Children and Adolescents with Multiple Sclerosis http://mssociety.ca/en/research/medmmo_20100729_3.htm http://mssociety.ca/en/research/medmmo_20100729_3.htm 29 Jul 2010 17:22:00 EST Nocebo effects in multiple sclerosis trials: a meta-analysis http://mssociety.ca/en/research/medmmo_20100729_2.htm http://mssociety.ca/en/research/medmmo_20100729_2.htm 29 Jul 2010 16:54:00 EST Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course http://mssociety.ca/en/research/medmmo_20100729.htm http://mssociety.ca/en/research/medmmo_20100729.htm 29 Jul 2010 16:08:00 EST Impact on activities of daily living using a functional electrical stimulation device to improve dropped foot in people with multiple sclerosis, measured by the Canadian Occupational Performance Measure http://mssociety.ca/en/research/medmmo_20100722_2.htm http://mssociety.ca/en/research/medmmo_20100722_2.htm 22 Jul 2010 11:52:00 EST Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients http://mssociety.ca/en/research/medmmo_20100722.htm http://mssociety.ca/en/research/medmmo_20100722.htm 22 Jul 2010 11:52:00 EST Two Medical Meetings (ACTRIMS and CMSC) Focus on Research Progress and Issues in MS Clinical Care http://mssociety.ca/en/research/medmmo_20100720.htm http://mssociety.ca/en/research/medmmo_20100720.htm 20 Jul 2010 10:02:00 EST Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach. http://mssociety.ca/en/research/medmmo_20100712.htm http://mssociety.ca/en/research/medmmo_20100712.htm 12 Jul 2010 11:55:00 EST Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis http://mssociety.ca/en/research/medmmo_20100706_3.htm http://mssociety.ca/en/research/medmmo_20100706_3.htm 06 Jul 2010 02:32:00 EST Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS http://mssociety.ca/en/research/medmmo_20100706_2.htm http://mssociety.ca/en/research/medmmo_20100706_2.htm 06 Jul 2010 02:32:00 EST A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis http://mssociety.ca/en/research/medmmo_20100706.htm http://mssociety.ca/en/research/medmmo_20100706.htm 06 Jul 2010 02:32:00 EST New perspectives in the natural history of multiple sclerosis http://mssociety.ca/en/research/medmmo_20100630_3.htm http://mssociety.ca/en/research/medmmo_20100630_3.htm 30 Jun 2010 11:15:00 EST The natural history of multiple sclerosis, a geographically based study: relapses and long-term disability http://mssociety.ca/en/research/medmmo_20100630_2.htm http://mssociety.ca/en/research/medmmo_20100630_2.htm 30 Jun 2010 11:15:00 EST Increasing use of disease modifying drugs for MS in Canada http://mssociety.ca/en/research/medmmo_20100630.htm http://mssociety.ca/en/research/medmmo_20100630.htm 30 Jun 2010 11:15:00 EST Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial http://mssociety.ca/en/research/medmmo_20100623_2.htm http://mssociety.ca/en/research/medmmo_20100623_2.htm 23 Jun 2010 10:17:00 EST Cross-sectional study assessing long-term safety of interferon-{beta}-1b for relapsing-remitting MS http://mssociety.ca/en/research/medmmo_20100623.htm http://mssociety.ca/en/research/medmmo_20100623.htm 23 Jun 2010 10:17:00 EST Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance http://mssociety.ca/en/research/medmmo_20100621.htm http://mssociety.ca/en/research/medmmo_20100621.htm 21 Jun 2010 12:45:00 EST MRI only conversion to multiple sclerosis following a clinically isolated syndrome http://mssociety.ca/en/research/medmmo_20100614.htm http://mssociety.ca/en/research/medmmo_20100614.htm 14 Jun 2010 03:00:00 EST What is the risk of permanent disability from a multiple sclerosis relapse? http://mssociety.ca/en/research/medmmo_20100607_2.htm http://mssociety.ca/en/research/medmmo_20100607_2.htm 08 Jun 2010 10:00:00 EST Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis http://mssociety.ca/en/research/medmmo_20100607.htm http://mssociety.ca/en/research/medmmo_20100607.htm 07 Jun 2010 10:15:00 EST Vitamin D and multiple sclerosis http://mssociety.ca/en/research/medmmo_20100603_2.htm http://mssociety.ca/en/research/medmmo_20100603_2.htm 03 Jun 2010 02:35:00 EST Progress on Experimental Therapies for MS, CCSVI Forum, and Much More, Reported at the American Academy of Neurology Meeting http://mssociety.ca/en/research/medmmo_20100603.htm http://mssociety.ca/en/research/medmmo_20100603.htm 03 Jun 2010 02:35:00 EST Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis http://mssociety.ca/en/research/medmmo_20100601_2.htm http://mssociety.ca/en/research/medmmo_20100601_2.htm 2 Jun 2010 10:22:00 EST Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial http://mssociety.ca/en/research/medmmo_20100601.htm http://mssociety.ca/en/research/medmmo_20100601.htm 1 Jun 2010 04:36:00 EST Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS http://mssociety.ca/en/research/medmmo_20100531.htm http://mssociety.ca/en/research/medmmo_20100531.htm 31 May 2010 03:24:00 EST Researchers pave way for the first coordinated international approach to MS stem cell research http://mssociety.ca/en/research/medmmo_20100525_2.htm http://mssociety.ca/en/research/medmmo_20100525_2.htm 28 May 2010 01:54:00 EST Psychosocial issue in children and adolescents with multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100525.htm http://www.mssociety.ca/en/research/medmmo_20100525.htm 25 May 2010 02:10:00 EST Crossover trial of gabapentin and memantine as treatment for acquired nystagmus http://www.mssociety.ca/en/research/medmmo_20100519.htm http://www.mssociety.ca/en/research/medmmo_20100519.htm 19 May 2010 03:16:00 EST Study Suggests that Smoking and Exposure to Epstein-Barr Virus May Interact as Risk Factors for Developing MS http://www.mssociety.ca/en/research/medmmo_20100510_2.htm http://www.mssociety.ca/en/research/medmmo_20100510_2.htm 10 May 2010 02:15:00 EST Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices http://www.mssociety.ca/en/research/medmmo_20100510.htm http://www.mssociety.ca/en/research/medmmo_20100510.htm 10 May 2010 02:15:00 EST Disease onset in familial and sporadic primary progressive multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100426_2.htm http://www.mssociety.ca/en/research/medmmo_20100426_2.htm 26 Apr 2010 10:20:00 EST Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts http://www.mssociety.ca/en/research/medmmo_20100426.htm http://www.mssociety.ca/en/research/medmmo_20100426.htm 26 Apr 2010 10:20:00 EST Relationship of cortical atrophy to fatigue in patients with multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100422_2.htm http://www.mssociety.ca/en/research/medmmo_20100422_2.htm 22 Apr 2010 14:20:00 EST Clinical trial of a formal group fatigue program in multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100422.htm http://www.mssociety.ca/en/research/medmmo_20100422.htm 22 Apr 2010 14:36:00 EST Pediatric focus continues to shed new light on MS http://www.mssociety.ca/en/research/medmmo_20100407.htm http://www.mssociety.ca/en/research/medmmo_20100407.htm 07 Apr 2010 18:37:00 EST Five Studies explore relationship between Epstein-Barr Virus and MS http://www.mssociety.ca/en/research/medmmo_20100323.htm http://www.mssociety.ca/en/research/medmmo_20100323.htm 23 Mar 2010 15:00:00 EST Early cognitive impairment in multiple sclerosis predicts disability outcome several years later http://www.mssociety.ca/en/research/medmmo_20100316COG.htm http://www.mssociety.ca/en/research/medmmo_20100316COG.htm 17 Mar 2010 09:45:00 EST Ibudilast in relapsing-remitting multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100316IBU.htm http://www.mssociety.ca/en/research/medmmo_20100316IBU.htm 17 Mar 2010 09:45:00 EST Antiviral immune response in patients with multiple sclerosis and healthy siblings http://www.mssociety.ca/en/research/medmmo_20100316.htm http://www.mssociety.ca/en/research/medmmo_20100316.htm 16 Mar 2010 09:30:00 EST Results of Phase II "CHOICE" Study Published, Showing that Daclizumab Reduced Disease Activity in Relapsing MS, and Revealing Novel Immune Mechanism http://www.mssociety.ca/en/research/medmmo_20100304.htm http://www.mssociety.ca/en/research/medmmo_20100304.htm 04 Mar 2010 09:05:00 EST Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100303.htm http://www.mssociety.ca/en/research/medmmo_20100303.htm 03 Mar 2010 11:15:00 EST MRI of the corpus callosum in multiple sclerosis: association with disability http://www.mssociety.ca/en/research/medmmo_20100303_corpus.htm http://www.mssociety.ca/en/research/medmmo_20100303_corpus.htm 03 Mar 2010 11:15:00 EST Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene http://www.mssociety.ca/en/research/medmmo_20100303_STAT3.htm http://www.mssociety.ca/en/research/medmmo_20100303_STAT3.htm 03 Mar 2010 11:15:00 EST Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy http://www.mssociety.ca/en/research/medmmo_20100301.htm http://www.mssociety.ca/en/research/medmmo_20100301.htm 01 Mar 2010 15:45:00 EST High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100216.htm http://www.mssociety.ca/en/research/medmmo_20100216.htm 16 Feb 2010 10:30:00 EST The rising prevalence and changing age distribution of multiple sclerosis in Manitoba http://www.mssociety.ca/en/research/medmmo_20100202.htm http://www.mssociety.ca/en/research/medmmo_20100202.htm 02 Feb 2010 13:00:00 EST Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial http://www.mssociety.ca/en/research/medmmo_20100129FAM.htm http://www.mssociety.ca/en/research/medmmo_20100129FAM.htm 29 Jan 2010 15:40:00 EST Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100129.htm http://www.mssociety.ca/en/research/medmmo_20100129.htm 29 Jan 2010 10:45:00 EST Results Published from Phase 3 Study of Oral Cladribine in Relapsing-Remitting MS http://www.mssociety.ca/en/research/medmmo_20100128.htm http://www.mssociety.ca/en/research/medmmo_20100128.htm 28 Jan 2010 11:30:00 EST Positive Results Published on Clinical Trials of Oral FTY720 (Fingolimod) for Relapsing MS - Novartis Applies to FDA and European Regulatory Agency for Approval http://www.mssociety.ca/en/research/medmmo_20100127.htm http://www.mssociety.ca/en/research/medmmo_20100127.htm 27 Jan 2010 14:30:00 EST Regional brain atrophy in primary fatigued patients with multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100126.htm http://www.mssociety.ca/en/research/medmmo_20100126.htm 26 Jan 2010 11:30:00 EST No Effect of Parental Age on Risk of Multiple Sclerosis: A Population-Based Study http://www.mssociety.ca/en/research/medmmo_20100121.htm http://www.mssociety.ca/en/research/medmmo_20100121.htm 21 Jan 2010 14:45:00 EST Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results http://www.mssociety.ca/en/research/medmmo_20100112.htm http://www.mssociety.ca/en/research/medmmo_20100112.htm 12 Jan 2010 16:15:00 EST A randomized trial of memantine as treatment for spasticity in multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100111.htm http://www.mssociety.ca/en/research/medmmo_20100111.htm 11 Jan 2010 10:05:00 EST HLA-DRB1 and month of birth in multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20100108.htm http://www.mssociety.ca/en/research/medmmo_20100108.htm 08 Jan 2010 12:25:00 EST Callosal lesion predicts future attacks after clinically isolated syndrome http://www.mssociety.ca/en/research/medmmo_20100104.htm http://www.mssociety.ca/en/research/medmmo_20100104.htm 04 Jan 2010 11:15:00 EST A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS http://www.mssociety.ca/en/research/medmmo_20100104_MRI.htm http://www.mssociety.ca/en/research/medmmo_20100104_MRI.htm 04 Jan 2010 11:15:00 EST Positive Results Announced in Phase II Study of IV Ocrelizumab in Relapsing-Remitting MS http://www.mssociety.ca/en/research/medmmo_20091210.htm http://www.mssociety.ca/en/research/medmmo_20091210.htm 10 Dec 2009 10:55:00 EST Body size and risk of MS in two cohorts of US women http://www.mssociety.ca/en/research/medmmo_20091124.htm http://www.mssociety.ca/en/research/medmmo_20091124.htm 24 Nov 2009 13:15:00 EST Chronic cerebrospinal venous insufficiency (CCSVI) and MS http://www.mssociety.ca/en/research/medmmo_20091021_faq.htm http://www.mssociety.ca/en/research/medmmo_20091021_faq.htm 21 Nov 2009 10:30:00 EST Impact of Multiple Sclerosis Relapses on Progression Diminishes with time http://www.mssociety.ca/en/research/medmmo_20091118.htm http://www.mssociety.ca/en/research/medmmo_20091118.htm 18 Nov 2009 10:30:00 EST Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial http://www.mssociety.ca/en/research/medmmo_20091109.htm http://www.mssociety.ca/en/research/medmmo_20091109.htm 09 Nov 2009 15:30:00 EST Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20091027.htm http://www.mssociety.ca/en/research/medmmo_20091027.htm 27 Oct 2009 11:15:00 EST Consideration of the risk of secondary leukemia after mitoxantrone in multiple sclerosis populations is required http://www.mssociety.ca/en/research/medmmo_20091027mito.htm http://www.mssociety.ca/en/research/medmmo_20091027mito.htm 27 Oct 2009 11:15:00 EST Research into Blood Flow in the Brain and Venous Insufficiency, or CCSVI, in MS http://www.mssociety.ca/en/research/medmmo_20091021.htm http://www.mssociety.ca/en/research/medmmo_20091021.htm 21 Oct 2009 14:30:00 EST Two reports for Management of Trigeminal Neuralgia in Multiple Sclerosis http://www.mssociety.ca/en/research/medmmo_20091020.htm http://www.mssociety.ca/en/research/medmmo_20091020.htm 20 Oct 2009 12:45:00 EST PreCISe Study Results – Showing Benefit of Copaxone® in People at High Risk for MS http://www.mssociety.ca/en/research/medmmo_20091020precise.htm http://www.mssociety.ca/en/research/medmmo_20091020precise.htm 20 Oct 2009 12:45:00 EST Therapeutic Strategies for MS and More Highlighted at ECTRIMS Conference http://www.mssociety.ca/en/research/medmmo_20091015.htm http://www.mssociety.ca/en/research/medmmo_20091015.htm 15 Oct 2009 14:15:00 EST Preliminary work suggests that minocycline as add-on therapy may offer improved efficacy of glatiramer acetate in relapsing-remitting multiple sclerosis . Authors suggest further research needed. http://www.mssociety.ca/en/research/medmmo_20091013.htm http://www.mssociety.ca/en/research/medmmo_20091013.htm 13 Oct 2009 10:45:00 EST 250 mug or 500 mug interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study http://www.mssociety.ca/en/research/medmmo_20090922.htm http://www.mssociety.ca/en/research/medmmo_20090922.htm 22 Sep 2009 10:45:00 EST Asymptomatic reactivation of JC virus in patients treated with natalizumab http://www.mssociety.ca/en/research/medmmo_20090922JC.htm http://www.mssociety.ca/en/research/medmmo_20090922JC.htm 22 Sep 2009 10:45:00 EST Correlation between disability and transcranial magnetic stimulation abnormalities in patients with multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20090910.htm http://www.mssociety.ca/en/research/medmmo_20090910.htm 10 Sep 2009 15:30:00 EST Effect of immigration on multiple sclerosis female to male ratio in Canada: the Canadian Collaborative Study http://www.mssociety.ca/en/research/medmmo_20090909.htm http://www.mssociety.ca/en/research/medmmo_20090909.htm 9 Sep 2009 13:00:00 EST Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20090903_mri.htm http://www.mssociety.ca/en/research/medmmo_20090903_mri.htm 03 Sep 2009 13:30:00 EST Gestational diabetes and multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20090903.htm http://www.mssociety.ca/en/research/medmmo_20090903.htm 03 Sep 2009 11:30:00 EST Care Given to People with MS by Family Members Presents Unique Challenges - Study funded by National MS Society points to need for respite and mental health support for family care givers http://www.mssociety.ca/en/research/medmmo_20090902.htm http://www.mssociety.ca/en/research/medmmo_20090902.htm 02 Sep 2009 09:30:00 EST Sponsor Reports Positive Results of Clinical Trial of Zenvia™ for Pseudobulbar Affect (Uncontrollable Laughing and/or Crying) http://www.mssociety.ca/en/research/medmmo_20090831.htm http://www.mssociety.ca/en/research/medmmo_20090831.htm 31 Aug 2009 13:15:00 EST Pilot study of a cognitive intervention program for persons with multiple sclerosis. http://www.mssociety.ca/en/research/medmmo_20090818.htm http://www.mssociety.ca/en/research/medmmo_20090818.htm 18 Aug 2009 10:00:00 EST The impact of physical activity on fatigue, depression and quality of life in persons with multiple sclerosis. http://www.mssociety.ca/en/research/medmmo_20090730.htm http://www.mssociety.ca/en/research/medmmo_20090730.htm 30 Jul 2009 15:45:00 EST Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial In Secondary Progressive Multiple Sclerosis http://www.mssociety.ca/en/research/medmmo_20090729.htm http://www.mssociety.ca/en/research/medmmo_20090729.htm 29 Jul 2009 14:45:00 EST Study Adds Evidence that Smoking Worsens MS, and Quitting May Help http://www.mssociety.ca/en/research/medmmo_20090728.htm http://www.mssociety.ca/en/research/medmmo_20090728.htm 28 Jul 2009 09:45:00 EST "Benign” Course of MS Evaluated with MRI and Other Imaging Methods by European Collaborators http://www.mssociety.ca/en/research/medmmo_20090722.htm http://www.mssociety.ca/en/research/medmmo_20090722.htm 22 Jul 2009 13:00:00 EST Parent-of-origin effect in multiple sclerosis. Observations from interracial matings http://www.mssociety.ca/en/research/medmmo_20090706parent.htm http://www.mssociety.ca/en/research/medmmo_20090706parent.htm 06 Jul 2009 11:00:00 EST Age of onset in concordant twins and other relative pairs with multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20090706twins.htm http://www.mssociety.ca/en/research/medmmo_20090706twins.htm 06 Jul 2009 11:00:00 EST Two Studies Report Finding New Genes and Gene Regions that Make People Susceptible to MS http://www.mssociety.ca/en/research/medmmo_20090706.htm http://www.mssociety.ca/en/research/medmmo_20090706.htm 06 Jul 2009 11:00:00 EST Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction http://www.mssociety.ca/en/research/medmmo_20090629.htm http://www.mssociety.ca/en/research/medmmo_20090629.htm 29 Jun 2009 10:00:00 EST Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a http://www.mssociety.ca/en/research/medmmo_20090629stat.htm http://www.mssociety.ca/en/research/medmmo_20090629stat.htm 29 Jun 2009 10:00:00 EST Two Medical Meetings (ACTRIMS and CMSC) Focus on MS Risk Factors and Quality of Life Issues http://www.mssociety.ca/en/research/medmmo_20090624.htm http://www.mssociety.ca/en/research/medmmo_20090624.htm 24 Jun 2009 11:05:00 EST Remyelination capacity of the MS brain decreases with disease chronicity http://www.mssociety.ca/en/research/medmmo_20090623.htm http://www.mssociety.ca/en/research/medmmo_20090623.htm 23 Jun 2009 11:05:00 EST Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria http://www.mssociety.ca/en/research/medmmo_20090617.htm http://www.mssociety.ca/en/research/medmmo_20090617.htm 17 Jun 2009 01:50:00 EST Randomized Clinical Trial of Balance-Based Torso Weighting for Improving Upright Mobility in People with Multiple Sclerosis http://www.mssociety.ca/en/research/medmmo_20090615.htm http://www.mssociety.ca/en/research/medmmo_20090615.htm 15 Jun 2009 02:15:00 EST Report of American Academy of Neurology Meeting Seattle April 2009 http://www.mssociety.ca/en/research/medmmo_20090609.htm http://www.mssociety.ca/en/research/medmmo_20090609.htm 09 Jun 2009 15:30:00 EST Parity and secondary progression in multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20090608.htm http://www.mssociety.ca/en/research/medmmo_20090608.htm 08 Jun 2009 10:00:00 EST Update on oral therapies for MS reported at the American Academy of Neurology Meeting http://www.mssociety.ca/en/research/medmmo_20090526.htm http://www.mssociety.ca/en/research/medmmo_20090526.htm 26 May 2009 10:00:00 EST Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease http://www.mssociety.ca/en/research/medmmo_20090519.htm http://www.mssociety.ca/en/research/medmmo_20090519.htm 19 May 2009 10:39:00 EST The relationship between handedness and risk of multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20090514.htm http://www.mssociety.ca/en/research/medmmo_20090514.htm 14 May 2009 10:30:00 EST Multiple Sclerosis and Academic Work: Socio-Spatial Strategies Adopted to Maintain Employment http://www.mssociety.ca/en/research/medmmo_20090511.htm http://www.mssociety.ca/en/research/medmmo_20090511.htm 11 May 2009 11:30:00 EST The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosisrelated neurogenic bladder dysfunction http://www.mssociety.ca/en/research/medmmo_20090504.htm http://www.mssociety.ca/en/research/medmmo_20090504.htm 04 May 2009 10:30:00 EST Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T http://www.mssociety.ca/en/research/medmmo_20090430.htm http://www.mssociety.ca/en/research/medmmo_20090430.htm 30 Apr 2009 14:30:00 EST The search for responsive clinical endpoints in primary progressive multiple sclerosis http://www.mssociety.ca/en/research/medmmo_20090430ppms.htm http://www.mssociety.ca/en/research/medmmo_20090430ppms.htm 30 Apr 2009 14:30:00 EST Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors http://www.mssociety.ca/en/research/medmmo_20090420.htm http://www.mssociety.ca/en/research/medmmo_20090420.htm 20 Apr 2009 11:30:00 EST Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2-year longitudinal study http://www.mssociety.ca/en/research/medmmo_20090414.htm http://www.mssociety.ca/en/research/medmmo_20090414.htm 14 Apr 2009 10:00:00 EST Efficacy of treatment of MS with IFN{beta}-1b or glatiramer acetate by monthly brain MRI in the BECOME study http://www.mssociety.ca/en/research/medmmo_20090325.htm http://www.mssociety.ca/en/research/medmmo_20090325.htm 25 Mar 2009 10:30:00 EST Studies Reported: Function, Combination Drug Therapy, Cognition, and Causation http://www.mssociety.ca/en/research/medmmo_20090318.htm http://www.mssociety.ca/en/research/medmmo_20090318.htm 18 Mar 2009 15:30:00 EST Genetics Studies Yield New Clues to Why People Get MS http://www.mssociety.ca/en/research/medmmo_20090317.htm http://www.mssociety.ca/en/research/medmmo_20090317.htm 17 Mar 2009 09:00:00 EST New Studies Bolster Possible Link Between Epstein-Barr Virus and MS http://www.mssociety.ca/en/research/medmmo_20090316.htm http://www.mssociety.ca/en/research/medmmo_20090316.htm 16 Mar 2009 14:30:00 EST Predicting accidental falls in people with multiple sclerosis -- a longitudinal study http://www.mssociety.ca/en/research/medmmo_20090306.htm http://www.mssociety.ca/en/research/medmmo_20090306.htm 06 Mar 2009 11:00:00 EST Young Smokers Increase Risk for Multiple Sclerosis http://www.mssociety.ca/en/research/medmmo_20090303.htm http://www.mssociety.ca/en/research/medmmo_20090303.htm 03 Mar 2009 11:00:00 EST Breastfeeding may have an impact on reducing Multiple Sclerosis Relapses http://www.mssociety.ca/en/research/medmmo_20090303bf.htm http://www.mssociety.ca/en/research/medmmo_20090303bf.htm 03 Mar 2009 11:00:00 EST Results of the Avonex Combination Trial (ACT) in relapsing-remittng MS http://www.mssociety.ca/en/research/medmmo_20090223.htm http://www.mssociety.ca/en/research/medmmo_20090223.htm 23 Feb 2009 03:00:00 EST Incidence of acquired demyelination of the central nervous system in Canadian children http://www.mssociety.ca/en/research/medmmo_20090211.htm http://www.mssociety.ca/en/research/medmmo_20090211.htm 11 Feb 2009 09:00:00 EST Researchers Report Good Results from Small Study of Stem Cell Therapy to “Reboot” Immune System in MS http://www.mssociety.ca/en/research/medmmo_20090209.htm http://www.mssociety.ca/en/research/medmmo_20090209.htm 09 Feb 2009 14:00:00 EST Genetic study supports vitamin D deficiency as an environmental factor in MS susceptibility http://www.mssociety.ca/en/research/medmmo_20090205.htm http://www.mssociety.ca/en/research/medmmo_20090205.htm 05 Feb 2009 01:00:00 EST Oral Cladribine Reduces MS Relapses in Phase 3 Clinical Trial http://www.mssociety.ca/en/research/medmmo_20090128.htm http://www.mssociety.ca/en/research/medmmo_20090128.htm 28 Jan 2009 10:00:00 EST Restless Leg Syndrome in multiple sclerosis:A case-control study http://www.mssociety.ca/en/research/medmmo_20090115.htm http://www.mssociety.ca/en/research/medmmo_20090115.htm 15 Jan 2009 10:00:00 EST Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support http://www.mssociety.ca/en/research/medmmo_20090108.htm http://www.mssociety.ca/en/research/medmmo_20090108.htm 8 Jan 2009 15:00:00 EST Oral FTY720 (Fingolimod) Reduced Relapse Rate More Effectively Than Avonex in Initial Results of One-Year Study in Relapsing-Remitting MS http://www.mssociety.ca/en/research/medmmo_20090105fty.htm http://www.mssociety.ca/en/research/medmmo_20090105fty.htm 05 Jan 2009 15:00:00 EST Dr. Brenda Banwell, a well known Canadian pediatric researcher, is an author on 2 papers about the use of MRI in children with MS, published in Neurology. 2006 Nov 26 (Epub ahead of print) http://www.mssociety.ca/en/research/medmmo_20090105.htm http://www.mssociety.ca/en/research/medmmo_20090105.htm 05 Jan 2009 15:00:00 EST